Editorial
The role of robot-assisted mastectomy: promise, challenges, and evidence gaps
Gland Surgery
2025;
14
(4)
:579-583
.
(30 April 2025)
Original Article
Malignant risk prediction of cystic-solid thyroid nodules using a comprehensive model integrating clinical and ultrasound features, ultrasound radiomics, and deep transfer learning
Gland Surgery
2025;
14
(4)
:584-596
.
(30 April 2025)
Value of dynamic contrast-enhanced ultrasound in predicting cervical lymph node metastasis in papillary thyroid carcinoma patients with Hashimoto’s thyroiditis
Gland Surgery
2025;
14
(4)
:597-610
.
(30 April 2025)
Fluorescent intraoperative tissue angiography during breast reduction: a single institution, single surgeon study evaluating decrease in complication rates with acquired proficiency
Gland Surgery
2025;
14
(4)
:611-617
.
(30 April 2025)
Serum thyroid-stimulating hormone as a diagnostic marker for cancer in atypia of undetermined significance/follicular lesion of undetermined significance nodules
Gland Surgery
2025;
14
(4)
:618-627
.
(30 April 2025)
Correlation study of tumor-infiltrating lymphocytes (TILs) and subtypes analysis before and after neoadjuvant chemotherapy in triple-negative breast cancer
Gland Surgery
2025;
14
(4)
:628-645
.
(30 April 2025)
Unveiling the enigma: understanding the complex disease course of granulomatous mastitis and seeking ways to shorten it
Gland Surgery
2025;
14
(4)
:646-657
.
(30 April 2025)
Development and validation of an intratumoral-peritumoral deep transfer learning fusion model for differentiating BI-RADS 3–4 breast nodules
Gland Surgery
2025;
14
(4)
:658-669
.
(30 April 2025)
The development and validation of biomarkers-based scoring systems for predicting early recurrence in patients with borderline resectable pancreatic cancer undergoing resection after neoadjuvant therapy
Gland Surgery
2025;
14
(4)
:670-686
.
(30 April 2025)
Development and validation of a screening model for benign and malignant breast masses based on S-Detect and microvascular flow imaging
Gland Surgery
2025;
14
(4)
:687-698
.
(30 April 2025)
A web-based predictive model for secondary skin infections in breast cancer patients undergoing reconstruction
Gland Surgery
2025;
14
(4)
:699-713
.
(30 April 2025)
Recent changes in surgical outcomes and preoperative biliary drainage with the increased use of neoadjuvant chemotherapy in pancreatic cancer patients undergoing pancreatoduodenectomy: a single-center retrospective study
Gland Surgery
2025;
14
(4)
:714-725
.
(30 April 2025)
Correlation between ultrasound-based hepatic steatosis grade and thyroid hormone levels
Gland Surgery
2025;
14
(4)
:726-737
.
(30 April 2025)
Review Article
Liquid biopsy in breast cancer: a practical guide for surgeons
Gland Surgery
2025;
14
(4)
:754-760
.
(30 April 2025)
Intra-parotid lymph node metastasis in primary parotid gland cancer: a narrative review of its significance, anatomic distribution, and therapeutic implications
Gland Surgery
2025;
14
(4)
:761-770
.
(30 April 2025)
Editorial Commentary
Critical appraisal of the 2 mm threshold in ductal carcinoma in situ: methodological concerns in meta-analysis of margin width and local recurrence risk
Gland Surgery
2025;
14
(4)
:771-775
.
(30 April 2025)
Should abemaciclib candidacy be an indication for ALND?—commentary on SENOMAC post-hoc analysis
Gland Surgery
2025;
14
(4)
:776-780
.
(30 April 2025)
Risking arm lymphedema in more than a hundred patients to benefit one patient—is it worth it?
Gland Surgery
2025;
14
(4)
:781-784
.
(30 April 2025)
T-DM1: a promising adjuvant therapy option for stage I HER2-positive breast cancer—interpreting ATEMPT trial results from a clinical perspective
Gland Surgery
2025;
14
(4)
:785-790
.
(30 April 2025)
Dose-dense adjuvant chemotherapy for high-risk early breast cancer: its role in the era of personalised oncology
Gland Surgery
2025;
14
(4)
:791-796
.
(30 April 2025)
Oncoplastic breast-conserving surgery: advancing oncological outcomes and aesthetic standards in breast cancer treatment
Gland Surgery
2025;
14
(4)
:797-799
.
(30 April 2025)
Erratum
Erratum: Lysyl oxidase promotes anaplastic thyroid carcinoma cell proliferation and metastasis mediated via BMP1
Gland Surgery
2025;
14
(4)
:800-802
.
(30 April 2025)
